Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the Pediatric Preclinical Testing Program.
about
Molecular profiling of childhood cancer: Biomarkers and novel therapiesNetwork analysis identifies an HSP90-central hub susceptible in ovarian cancerXenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery.Advances in HSP27 and HSP90-targeting strategies for glioblastoma.
P2860
Initial testing (stage 1) of ganetespib, an Hsp90 inhibitor, by the Pediatric Preclinical Testing Program.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Initial testing (stage 1) of g ...... c Preclinical Testing Program.
@ast
Initial testing (stage 1) of g ...... c Preclinical Testing Program.
@en
Initial testing (stage 1) of g ...... c Preclinical Testing Program.
@nl
type
label
Initial testing (stage 1) of g ...... c Preclinical Testing Program.
@ast
Initial testing (stage 1) of g ...... c Preclinical Testing Program.
@en
Initial testing (stage 1) of g ...... c Preclinical Testing Program.
@nl
prefLabel
Initial testing (stage 1) of g ...... c Preclinical Testing Program.
@ast
Initial testing (stage 1) of g ...... c Preclinical Testing Program.
@en
Initial testing (stage 1) of g ...... c Preclinical Testing Program.
@nl
P2093
P2860
P356
P1476
Initial testing (stage 1) of g ...... c Preclinical Testing Program.
@en
P2093
C Patrick Reynolds
Catherine A Billups
E Anders Kolb
Hernan Carol
John M Maris
Malcolm A Smith
Min H Kang
Peter J Houghton
Raushan T Kurmasheva
Richard B Lock
P2860
P356
10.1002/PBC.24451
P577
2013-01-09T00:00:00Z